STVN News and Press, Stevanato Group S.p.A. From 05/11/24

2024-05-11 07:21:06 ET Stevanato Group S.p.A. (STVN) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET Company Participants Lisa Miles – Investor Relations Franco Stevanato – Executive Chairman Marco Dal Lago – Chief Financial Officer ...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 20.3% to $0.0699 on volume of 164,902,840 shares Safe and Green Development Corporation (SGD) rose 36.7% to $0.8477 on volume of 100,466,382 shares PROSHARES TRUST (SQQQ) fell 0.6% to $1...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 22.2% to $0.071 on volume of 95,914,661 shares Pop Culture Group Co. Ltd (CPOP) rose 128.8% to $3.89 on volume of 39,763,492 shares Safe and Green Development Corporation (SGD) rose 40.7...

2024-05-09 07:29:52 ET More on Stevanato Group Stevanato: Destocking And Valuation Risk (Rating Downgrade) Stevanato Group S.p.A. (STVN) Q4 2023 Earnings Call Transcript Stevanato Group stock slides on pricing upsized stock offering to raise $330 million Stev...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2024. First Quarter 2024 Highlights ...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Bank of America Securities Healthcare Conference taking p...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2024 on Thursday, May 9, 20...

2024-04-24 20:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-04 08:24:22 ET More on Stevanato Group Stevanato: Destocking And Valuation Risk (Rating Downgrade) Stevanato Group stock slides on pricing upsized stock offering to raise $330 million Read the full article on Seeking Alpha For further details see: ...